| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |